Search Results - "Hamisch, C"

Stereotactic brachytherapy using iodine 125 seeds for the treatment of primary and recurrent anaplastic glioma WHO° III by Suchorska, B., Hamisch, C., Treuer, H., Mahnkopf, K., Lehrke, R. E., Kocher, M., Ruge, M. I., Voges, J.

“…The current study analyzed the outcome after stereotactic brachytherapy (SBT) using iodine-125 seeds in anaplastic astrocytoma, oligoastrocytoma or…”
Get full text

O7.05 DIFFERENTIATION OF LOCAL RECURRENT BRAIN METASTASIS FROM RADIATION-INDUCED CHANGES USING O-(2-[18F]FLUOROETHYL)-L-TYROSINE PET by Galldiks, N., Ruge, M. I., Hamisch, C., Stoffels, G., Ceccon, G., Rapp, M., Sabel, M., Langen, K.

“…BACKGROUND: The aim of this study was to investigate the potential of O-(2-[18F]fluoroethyl)-L-tyrosine (18F-FET) PET for differentiating local recurrent brain…”
Get full text

P17.76 LOW-DOSE RATE STEREOTACTIC IODINE-125 BRACHYTHERAPY FOR THE TREATMENT OF INOPERABLE PRIMARY AND RECURRENT GLIOBLASTOMA: SINGLE-CENTER EXPERIENCE WITH 201 CASES by Kickingereder, P., Hamisch, C., Suchorska, B., Galldiks, N., Visser-Vandewalle, V., Goldbrunner, R., Kocher, M., Treuer, H., Voges, J., Ruge, M. I.

“…BACKGROUND: Treatment options for inoperable glioblastoma are limited. Low-dose-rate stereotactic iodine-125 brachytherapy (SBT) has been reported as an…”
Get full text

High-dose chemotherapy with autologous PBSC transplantation for poor prognosis germ cell tumors: a retrospective monocenter analysis of 44 cases by Mohr, M, Hartig, I, Kessler, T, Hamisch, C, Kliesch, S, Krug, U, Spieker, T, Semik, M, Wiebe, K, Pühse, G, Hertle, L, Liersch, R, Müller-Tidow, C, Mesters, R M, Berdel, W E

“…Germ cell cancer (GCC) is curable in metastatic stages. The International Germ Cell Cancer Collaborative Group (IGCCCG) reports a poor prognosis subgroup with…”
Get full text

P05.37 Hypofractionated radiosurgery for benign skull base tumors by Daniel, R, Hamisch, C, Grau, S, Jablonska, K, Baues, C, Kocher, M, Treuer, H, Ruge, M

“…Abstract Background The use of single fraction stereotactic radiosurgery (SRS) is limited by tumour size (>3cm) and/or close proximity to critical structures…”
Get full text

JS05.5.A INTRAOPERATIVE MRI-GUIDED RESECTION IS NOT SUPERIOR TO 5-ALA-GUIDANCE IN NEWLY DIAGNOSED GLIOBLASTOMA: A PROSPECTIVE CONTROLLED MULTICENTER CLINICAL TRIAL by Roder, C, Stummer, W, Coburger, J, Scherer, M, Haas, P, von der Brelie, C, Kamp, M, Löhr, M, Hamisch, C, Skardelly, M, Scholz, T, Schipmann, S, Rathert, J, Brand, C, Pala, A, Ernemann, U, Stockhammer, F, Gerlach, R, Kremer, P, Goldbrunner, R, Ernestus, R, Sabel, M, Rohde, V, Tabatabai, G, Martus, P, Bisdas, S, Ganslandt, O, Unterberg, A, Wirtz, C, Tatagiba, M

“…Abstract BACKGROUND Prospective data suggested a superiority of intraoperative MRI (iMRI) over 5-aminolevulinic acid (5-ALA) for achieving complete resections…”
Get full text

P05.69 Independent risk factors for pre- and postoperative seizures in meningioma patients identified by logistic regression analysis by Goertz, L, Hamisch, C, Erdner, N, Muders, H, Goldbrunner, R, von Spreckelsen, N, Stavrinou, P, Krischek, B, Timmer, M

“…Abstract Background To identify independent risk factors of pre- and postoperative seizures in meningioma patients. Material and Methods This is a…”
Get full text

P09.56 Comparison of the effect of different treatment strategies within discrepant health-care systems on survival of glioblastoma patients by Stavrinou, P., Kalyvas, A., Katsigiannis, S., Hamisch, C., Krischek, B., Stranjalis, G., Goldbrunner, R.

“…OBJECTIVE: Although interdisciplinary, longitudinal treatment of glioblastoma patients is standard-of-care for most countries, its effect on glioblastoma…”
Get full text

P08.34 Overall survival of primary high-grade gliomas of supra- and infratentorial midline structures by Hamisch, C. A., Kellermann, S., Blau, T., Grau, S., Goldbrunner, R., Ruge, M. I.

Get full text

P21.08 Stereotactic biopsy in elderly patients: risk assessment and impact on treatment decision by Kellermann, S. G., Hamisch, C. A., Hafkemeyer, V., Rueß, D., Grau, S. J., Ruge, M. I.

Get full text

O7.05DIFFERENTIATION OF LOCAL RECURRENT BRAIN METASTASIS FROM RADIATION-INDUCED CHANGES USING O-(2-[18F]FLUOROETHYL)-L-TYROSINE PET by Galldiks, N., Ruge, M.I., Hamisch, C., Stoffels, G., Ceccon, G., Rapp, M., Sabel, M., Langen, K.

“…BACKGROUND: The aim of this study was to investigate the potential of O-(2-[18F]fluoroethyl)-L-tyrosine (18F-FET) PET for differentiating local recurrent brain…”
Get full text

P17.76LOW-DOSE RATE STEREOTACTIC IODINE-125 BRACHYTHERAPY FOR THE TREATMENT OF INOPERABLE PRIMARY AND RECURRENT GLIOBLASTOMA: SINGLE-CENTER EXPERIENCE WITH 201 CASES by Kickingereder, P., Hamisch, C., Suchorska, B., Galldiks, N., Visser-Vandewalle, V., Goldbrunner, R., Kocher, M., Treuer, H., Voges, J., Ruge, M.I.

“…BACKGROUND: Treatment options for inoperable glioblastoma are limited. Low-dose-rate stereotactic iodine-125 brachytherapy (SBT) has been reported as an…”
Get full text

High-dose chemotherapy with autologous peripheral blood stem cell transplantation in patients with poor- and intermediate-prognosis metastatic germ cell tumors: A retrospective monocenter analysis of 44 cases by Mohr, M., Hartig, I., Kessler, T., Hamisch, C., Kliesch, S., Krug, U., Spieker, T., Semik, M., Wiebe, K., Puehse, G., Hertle, L., Mueller-Tidow, C., Mesters, R. M., Berdel, W. E.

“…Abstract only…”
Get full text